Proteome Sciences said this week that the company has in collaboration with researchers at Kings College Hospital NHS Foundation Trust identified and validated protein biomarkers for patient stratification in liver cancer.

Detailed in a paper published this week in EuPa Open Proteomics, the work used Proteome Sciences' mass spec-based proteomics services to identify markers for distinguishing between hepatocellular carcinoma and cholangiocarcinoma.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.